Merck MRK
NYSE MRK
$152.55 +3.56 (+2.39%)
At close: Aug 21, 2026 · 4:01 PM EDT

Merck (MRK) Change in Account Payables (2009)

Merck (MRK) posted quarterly Change in Account Payables of -$73.0 million for Q4 2009, down 19.67% quarter-over-quarter from -$61.0 million in Q3 2009.

Merck (MRK) Change in Account Payables (2009) Analysis & Trends

Merck (MRK) has reported Change in Account Payables for 1 consecutive years, with -$73.0 million the latest figure, recorded in Q4 2009.

  • In Q4 2009, Change in Account Payables changed N/A year-over-year to -$73.0 million; the TTM figure through Dec 2009 stood at -$113.0 million (changed N/A YoY), while the FY2025 annual figure was $110.0 million, down 39.56% from the prior year.
  • Change in Account Payables retreated to -$73.0 million in Q4 2009 per MRK's latest filing, from -$61.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at -$61.0 million in Q3 2009 and bottomed at -$73.0 million in Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 18.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2009 -73.00 Mn
Dec 31, 2009 -73.00 Mn
Sep 30, 2009 -61.00 Mn
Sep 30, 2009 -61.00 Mn